4//SEC Filing
Dolan Matthew Vincent 4
Accession 0001093557-23-000089
CIK 0001093557other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:14 PM ET
Size
5.0 KB
Accession
0001093557-23-000089
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Dolan Matthew Vincent
EVP, Strategy & Corporate Dev
Transactions
- Sale
Common Stock
2023-03-16$115.00/sh−2,303$264,845→ 33,569 total
Footnotes (2)
- [F1]On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan which was amended on December 6, 2022. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 33,569 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,704 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 4,096 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001914994
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:14 PM ET
- Size
- 5.0 KB